Rocket Health, which was founded in 2012, is Uganda’s leading telemedicine provider, providing an end-to-end healthcare experience to over 25,000 patients. The startup’s solution leverages four services: 24/7 teleconsultations, medicine delivery, home sample collection for laboratory diagnostic testing, and physical specialist clinic consultations. Creadev, an evergreen investment fund backed by the Mulliez family of French entrepreneurs, is leading Rocket Health’s $5 million Series A round. Creadev was joined in the round by existing early-stage African investors Grenfell Holdings and LoftyInc Capital Management.The startup will use the funding to expand further across Uganda and into Kenya. “Rocket Health is on a quest to make quality primary healthcare accessible, affordable and convenient to achieve the best outcomes for as many Africans as possible through the exponential power of technology,” said Dr Davis Musinguzi, Rocket Health’s founder and CEO. “We’re elated that the investment thesis of Creadev and the Mulliez family resonates deeply with this timeless vision of the Rocket Health founding team. Together, we shall build a sustainable digital healthcare value chain down to the last mile across Africa.” Pierre Fauvet and Sarah Ngamau of Creadev Africa said they were delighted to partner with Rocket Health on its mission to make healthcare accessible to the many in Sub-Saharan Africa. “We have been highly impressed by the creativity, tenacity and vibrant culture of the Rocket Health team, which holds an ambitious vision for the future of African primary care. The opportunities are countless, from data analytics to innovative distribution channels. Together with like-minded investors, we look forward to bringing our experience in retail, e-commerce, logistics and digital health to support Davis and his team as they revolutionise access to Healthcare in Africa,” they said.
